Methods of administering neutralizing anti-protease nexin-1 antibodies to treat hemophilia A
The present invention relates to a method and compositions for the treatment of haemorrhagic diseases.
1. A method for treating mild or moderate haemophilia A in a subject in need thereof, comprising the step of administering to said subject a protease nexin-1 activity inhibitor, wherein the protease nexin-1 activity inhibitor is an anti-protease nexin-1 neutralizing antibody.
2. The method of claim 1 , wherein the protease nexin-1 activity inhibitor is administered in combination with one or more coagulation factors.
3. The method of claim 2 , wherein the one or more coagulation factors is selected from the group consisting of factor VIII, factor IX, factor Vila, plasma-derived activated prothrombin complex and fibrinogen.
4. The method of claim 1 , wherein the protease nexin 1 activity inhibitor is fused to a platelet targeting agent.